Grading antiviral therapy in HCV-infected cirrhotic patients

Grading antiviral therapy in HCV-infected cirrhotic patients

Chronic hepatitis C (CHC) is a major cause of cirrhosis, end-stage liver disease, and hepatocellular carcinoma. The combination drug regimen of pegylated interferon-alpha (PEG-IFNα) and ribavirin is the approved and well-accepted standard-of-care for CHC. However, CHC patients with decompensated cir...

Full description

Bibliographic Details
Main Author: ZHANG Ying
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Hepatology 2013-02-01
Series:Linchuang Gandanbing Zazhi
Subjects:
hepatitis C
chronic
liver cirrhosis
antiviral therapy
Online Access:http://www.lcgdbzz.org/qk_content.asp?id=5240&ClassID=115155828

Similar Items

Similar Items